🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
1.240
-0.090 (-6.77%)
At close: Nov 20, 2026, 4:00 PM EST
1.249
+0.009 (0.71%)
After-hours: Nov 20, 2026, 7:34 PM EST

Seres Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.130.79---144.93
Revenue Growth
505.41%----336.33%
Cost of Revenue
40.255.668.13117.6109.65141.89
Gross Profit
-38.08-54.82-68.13-117.6-109.653.04
Selling, General & Admin
28.1239.1653.1877.570.2669.26
Other Operating Expenses
------1.73
Operating Expenses
28.1239.1653.1877.570.2667.53
Operating Income
-66.2-93.97-121.32-195.1-179.91-64.49
Interest Expense
----2.47-6.02-2.91
Interest & Investment Income
1.12.233.977.33.062.87
Other Non Operating Income (Expenses)
3.3916.599.29-0.1-0.02-0.55
EBT Excluding Unusual Items
-61.71-75.16-108.06-190.37-182.89-65.08
Gain (Loss) on Sale of Investments
---0.24-0.69-0.5
Gain (Loss) on Sale of Assets
26.2780.855.68---
Other Unusual Items
---23.4---
Pretax Income
-46.955.7-125.77-190.13-183.58-65.58
Earnings From Continuing Operations
-46.955.7-125.77-190.13-183.58-65.58
Earnings From Discontinued Operations
--125.9176.41-66.58-
Net Income
-46.955.70.14-113.72-250.16-65.58
Net Income to Common
-46.955.70.14-113.72-250.16-65.58
Net Income Growth
-4088.24%----
Shares Outstanding (Basic)
1098655
Shares Outstanding (Diluted)
1098655
Shares Change
10.70%14.16%21.40%18.44%17.86%14.93%
EPS (Basic)
-4.880.640.02-17.77-46.29-14.30
EPS (Diluted)
-4.880.640.00-17.77-46.29-14.30
EPS Growth
-14333.92%----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-63.970.87-148.99-125.33-238.64-2.88
Free Cash Flow Per Share
-6.640.10-19.18-19.58-44.16-0.63
Gross Margin
-----2.10%
Operating Margin
-3115.15%-11910.14%----44.50%
Profit Margin
-2209.55%721.93%----45.25%
Free Cash Flow Margin
-3010.35%109.63%----1.99%
EBITDA
-63.31-89.84-115.85-188.85-173.29-58.55
EBITDA Margin
------40.40%
D&A For EBITDA
2.894.135.476.246.635.95
EBIT
-66.2-93.97-121.32-195.1-179.91-64.49
EBIT Margin
------44.50%
Revenue as Reported
2.130.79---144.93
SEC Filings: 10-K · 10-Q